Cell Therapy Instruments Market Size, Share, Growth, Research and Forecast 2027

Publisher: The Insight Partners

The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The key driving growth factors for the market include increasing developments in cell therapy manufacturing and rising number of approvals for cell-based therapies; whereas, high cost of cell therapy production and cell therapy are expected to hinder market growth.

Request Sample Copy Of this Report @ https://www.theinsightpartners.com/sample/TIPRE00003481/

The List of Companies - Cell Therapy Instruments Market

1. Thermo Fisher Scientific Inc.
2. MERCK KGaA
3. Lonza
4. Cytiva (GE Healthcare Life Sciences)
5. Terumo Corporation
6. BD
7. Miltenyi Biotec
8. STEMCELL Technologies Inc.
9. Sartorius AG
10. Danaher Corporation (Beckman Coulter Inc.)

Based on the product, the cell therapy instruments market is segmented into consumables, equipment, systems, and software. In 2019, the consumables segment accounted for the highest share of the market. The growth of this segment is attributed to the rising research activities that demand reagents, kits, and lab wares in higher quantity. Also, the increased production of cell therapies for commercialization has influenced the market for the consumables segments. Additionally, the rising adoption of cell therapy has increased the demand for storage consumables to supply and distribute it to the desired places.

The report segments global cell therapy instruments market as follows:

By Product

• Consumables
• Equipment
  • Single-Use Equipment
  • Cell Processing Equipment
  • Other Equipment
• Systems and Software

By Cell Type

• Human Cells
  • Differentiated Cells
  • Stem Cells
• Animal Cells

By Process      

• Cell Processing
• Process Monitoring and Quality Control
• Cell Preservation, Distribution, and Handling

The increasing research activities in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to efficiently treat genetic disorders and improve immune system. Various market players provide consumables such as reagents kits, enzymes, instruments, equipment, and software to conduct a wide range of cell therapy processes.

Purchase Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00003481/

The use of equipment is important for the production of cell therapies such as T cells, HSC, NSC, PSC, and MSC. These cell therapy products are derived from human or animals cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies help preventing contamination and allows scaling up the production. For instance, companies such as Corning Incorporated; Thermo Fisher Scientific Inc.; Hitachi Chemical Advanced Therapeutics Solutions, LLC; Invetech; Miltenyi Biotec; and Cytiva (General Electric Company) have introduced various equipment and consumables for the cell therapy.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com